Market Tracker

07/29 6:28am ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.52
Data as of Jul 28
 -0.03 / -1.94%
Today’s Change
1.16
Today|||52-Week Range
3.18
+9.35%
Year-to-Date

Today’s Trading

Previous close1.55
Today’s open1.55
Day’s range-- - --
Volume1,804,974
Average volume (3 months)1,241,408
Market cap$277.8M
Dividend yield--
Data as of 07/28/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-22.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book4.10

Competitors

 Today’s
change
Today’s
% change
IGIGI Laboratories Inc-0.20-3.77%
ADMSAdamas Pharmaceutica...-0.44-2.64%
TTPHTetraphase Pharmaceu...-0.02-0.19%
SCMPSucampo Pharmaceutic...-0.11-1.78%
Data as of 07/28/2014

Financials

Next reporting dateSeptember 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts